APA

Christie J. D., Vaslef S., Chang P. K., May A. K., Gunn S. R., Yang S., Hardes K., Kahl L., Powley W. M., Lipson D. A., Bayliffe A. I. & Lazaar A. L. (20151104). A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. : Critical care medicine.

Chicago

Christie Jason D, Vaslef Steven, Chang Philip K, May Addison K, Gunn Scott R, Yang Shuying, Hardes Kelly, Kahl Lesley, Powley William M, Lipson David A, Bayliffe Andrew I and Lazaar Aili L. 20151104. A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. : Critical care medicine.

Harvard

Christie J. D., Vaslef S., Chang P. K., May A. K., Gunn S. R., Yang S., Hardes K., Kahl L., Powley W. M., Lipson D. A., Bayliffe A. I. and Lazaar A. L. (20151104). A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. : Critical care medicine.

MLA

Christie Jason D, Vaslef Steven, Chang Philip K, May Addison K, Gunn Scott R, Yang Shuying, Hardes Kelly, Kahl Lesley, Powley William M, Lipson David A, Bayliffe Andrew I and Lazaar Aili L. A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. : Critical care medicine. 20151104.